Showing 1-5 of 5 "Viral Diseases"

Status: Enrolling

Investigator: Ahmed Gaber

Study Coordinator: Joy Nolte

Phone: 713.441.6314

BK infection is an important cause of graft dysfunction and graft loss after renal transplantation. It has been widely accepted that emergence of BK virus correlates with the more potent immunosuppressive agents used to lower acute rejection rat ... Read more >

Status: Open Not Enrolling

Investigator: David Victor

Study Coordinator: Susan Dorman

Phone: 713.441.6316

The purpose of this study is to test the safety and efficacy of Civacir® to prevent the recurrence of Hepatitis C Virus (HCV) after liver transplant. ... Read more >

Status: Enrolling

Investigator: David Victor

Study Coordinator: Alejandro De La Torre

Phone: 000.000.0000

This registry will remain open for approximately 5 years. Subjects will be followed until Orthotopic Liver Transplant (OLT), resolution of liver decompensation, death, or conclusion of the registry. When laboratory tests and clinical assessments ... Read more >

Status: Enrolling

Investigator: Sherilyn Gordon Burroughs

Study Coordinator: Joel Cisneros

Phone: 713.441.6311

The primary objective of the study is to evaluate safety and efficacy of ELAD with respect to overall survival of subjects with a clinical diagnosis of alcohol-induced liver decompensation (AILD) through at least Study Day 91. The secondary o ... Read more >

Status: Enrolling

Investigator: Ahmed Gaber

Study Coordinator: Darrel Cleere

Phone: 713.441.6232

Rabbit antithymocyte globulin (rATG) is approved for the treatment of acute rejection following kidney transplantation and is routinely administered as a series of 5-7 consecutive daily doses via central intravenous catheter. This prolonged cour ... Read more >